Biomarkers in Patients with Left Ventricular Assist Device: An Insight on Current Evidence
Left ventricular assist devices (LVADs) have been representing a cornerstone therapy for patients with end-stage heart failure during the last decades. However, their use induces several pathophysiological modifications which are partially responsible for the complications that typically characteriz...
Main Authors: | Carlotta Sciaccaluga, Nicolò Ghionzoli, Giulia Elena Mandoli, Flavio D’Ascenzi, Marta Focardi, Serafina Valente, Matteo Cameli |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Biomolecules |
Subjects: | |
Online Access: | https://www.mdpi.com/2218-273X/12/2/334 |
Similar Items
-
A multidisciplinary approach for the emergency care of patients with left ventricular assist devices: A practical guide
by: Matteo Cameli, et al.
Published: (2022-08-01) -
Left Ventricular Mass with Delayed Enhancement as a Predictor of Major Events in Patients with Myocarditis with Preserved Ejection Fraction
by: Nicolò Ghionzoli, et al.
Published: (2022-10-01) -
Left Ventricular Assist Devices
by: Khuansiri Narajeenron, et al.
Published: (2017-04-01) -
Changes of Plasma Tris(hydroxymethyl)aminomethane and 5-Guanidino-3-methyl-2-oxopentanoic Acid as Biomarkers of Heart Remodeling after Left Ventricular Assist Device Support
by: Mengda Xu, et al.
Published: (2022-11-01) -
Significance of right ventricular function for the outcome of treatment and remodeling of the heart after left ventricular assist device implantation
by: Terzić Duško, et al.
Published: (2022-01-01)